Tealwood Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Tealwood Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-59,447	Closed	-$3.69M	–	131
2020 Q4	$3.69M	Sell	59,447 -3,753	-6%	-$231K	1.73%	6
2020 Q3	$3.81M	Sell	63,200 -2,236	-3%	-$135K	2.48%	4
2020 Q2	$3.85M	Sell	65,436 -175	-0.3%	-$10.5K	2.56%	4
2020 Q1	$3.66M	Sell	65,611 -2,436	-4%	-$149K	2.08%	7
2019 Q4	$4.37M	Buy	68,047 +660	+1%	+$37.8K	1.82%	4
2019 Q3	$3.42M	Buy	67,387 +314	+0.5%	+$14.8K	1.47%	16
2019 Q2	$3.04M	Buy	+67,073	New	+$3.12M	1.24%	34

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tealwood Asset Management's BMY Position: Q1 2021 in Review

Tealwood Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 59,447 shares — an estimated $3.69M sold.

Tealwood Asset Management first reported a position in BMY in Q2 2019 and held it in 7 quarters. The position peaked at $4.37M in Q4 2019. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

Tealwood Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
Tealwood Asset Management sold 59,447 Bristol-Myers Squibb shares in Q1 2021, an estimated $3.69M.
Tealwood Asset Management first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 7 quarters.
Tealwood Asset Management's Bristol-Myers Squibb position peaked at $4.37M in Q4 2019.
2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Tealwood Asset Management's 13F filing for Q1 2021, filed 21 Jun 2021.